Insiders Genmab A/S Nasdaq

Stocks

GMAB

US3723032062

Biotechnology & Medical Research

Market Closed - Nasdaq 00:00:00 12/09/2026 +04			5-day change	1st Jan Change
32.47 ^USD	+0.74%		-3.36%	+5.42%

09-08	Espiria Hållbar Framtid rose 4.5 percent in August, Vestas and Hansa Biopharma made positive contributions	FW
09-08	Barclays raises Genmab price target to 2,900 Danish kroner (2,500), reiterates overweight - BN	FW

Insiders

01/07/25	Genmab Announces Changes to Its Executive Committee	CI
01/07/25	Genmab's Chief Legal Officer Steps Down; Successor Named	MT
16/08/24	Genmab Names First Chief Technology, Chief Commercial Officers; COO to Exit	MT
16/08/24	Genmab A/S Announces Executive Changes	CI
14/03/24	Genmab A/S Announces Executive Changes	CI
28/03/23	Danish Biotechnology Group Genmab Names New Chief Strategy Officer	MT
28/03/23	Genmab A/S Announces Appointment of Martine van Vugt to Chief Strategy Officer and Promotes to Executive Vice President Effective March 29, 2023	CI
29/03/22	Genmab A/S Elects Elizabeth O’Farrell to the Board of Directors	CI
01/03/22	Genmab Appoints New Chief Legal Officer, Chief People Officer	MT
01/03/22	Genmab A/S Announces Appointments of Birgitte Stephensen to Chief Legal Officer and Chris Cozic to Chief People Officer	CI
22/02/21	Genmab Announces Appointment of Tahamtan Ahmadi to Newly Created Position of Chief Medical Officer, Head of Experimental Medicines	CI
27/03/20	Genmab A/S Appoints Pernille Erenbjerg as Deputy Chairman	CI
26/03/20	Genmab A/S Announces the Election of Mr. Jonathan Peacock to its Board of Directors for a One-Year Period	CI
10/03/20	Genmab A/S Announces Anthony Mancini Will Join the Company as Executive Vice President and Chief Operating Officer, Effective March 23, 2020	CI
22/02/20	Genmab' Chairman of the Board of Directors, Mats Pettersson to Step Down from the Board At Annual General Meeting on March 26, 2020	CI
31/10/19	Genmab A/S Announces Executive Changes	CI
11/03/19	Genmab A/S Announces Management Changes	CI
08/02/17	Genmab A/S Appoints Judith Klimovsky as Executive Vice President and Chief Development Officer, Effective February 13, 2017	CI
03/08/16	Genmab A/S Nominates Rolf Hoffmann to its Board of Directors	CI
26/03/15	Genmab A/S Announces Board Appointments	CI
17/04/13	Genmab A/S Elects Mats Pettersson to the Board of Directors	CI